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Highlights19
Sensitive assay for the detection of the most common and toxic microcystin variants20
Detection of free and cell bound microcystin for a true reflection of toxin content21
Novel, highly effective lysis method enabling fast and portable disruption of cells22
Validated to measure microcystins below 1 and 0.1 ng ml-1; free and intracellular23
Next generation planar waveguide biosensor combining quantification and ease of use 24
25
26
Abstract27
The study details the development of a fully validated, rapid and portable sensor based 28
method for the on-site analysis of microcystins in freshwater samples.  The process 29
employs a novel lysis method for the mechanical lysis of cyanobacterial cells, with 30
glass beads and a handheld frother in only 10 min.  The assay utilises an innovative 31
planar waveguide device that, via an evanescent wave excites fluorescent probes, for 32
amplification of signal in a competitive immunoassay, using an anti-microcystin 33
monoclonal with cross-reactivity against the most common, and toxic variants.  34
Validation of the assay showed the Limit of Detection (LOD) to be 0.78 ng ml-1 and the 35
CCβ to be 1 ng ml-1.  Robustness of the assay was demonstrated by intra- and inter-36
assay testing.  Intra-assay analysis had % C.V.s between 8 and 26% and recoveries 37
between 73 and 101%, with inter-assay analysis demonstrating % C.V.s between 5 and 38
14% and recoveries between 78 and 91%.  Comparison with LC-MS/MS showed a high 39
correlation (R2 = 0.9954) between the calculated concentrations of 5 different 40
Microcystis aeruginosa cultures for total microcystin content.  Total microcystin 41
content was ascertained by the individual measurement of free and cell-bound 42
microcystins.  Free microcystins can be measured to 1 ng ml-1, and with a 10-fold 43
concentration step in the intracellular microcystin protocol (which brings the sample 44
within the range of the calibration curve), intracellular pools may be determined to 0.1 45
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ng ml-1.  This allows the determination of microcystins at and below the World Health 46
Organisation (WHO) guideline value of 1 µg l-1.  This sensor represents a major 47
advancement in portable analysis capabilities and has the potential for numerous other 48
applications. 49
50
Keywords: Microcystin, planar waveguide, portable biosensor, novel lysis, blue-green 51
algae and cyanobacteria52
53
1. Introduction54
55
Cyanobacteria (Domain Bacteria) originate from the Precambrian era, 3.4 billion years 56
ago and were the first prokaryotes to use water in the fixation of carbon dioxide [1].  57
They are widespread throughout global waters, both marine and freshwater, 58
encompassing, not only hot tropical to temperate waters, but even the chilly waters of 59
the Antarctic ice shelves [2].  Of the many types of cyanobacteria, Microcystis 60
aeruginosa (predominantly freshwater) is the most common species, which produces 61
microcystins.  In addition to Microcystis, microcystins are also produced by the 62
following genera: Anabaena, Nostoc, Planktothrix, Anabaenopsis and 63
Hapalosiphon [2].  Microcystins are cyclic heptapeptides with the structure; cyclo-(D-64
Alanine-X-D-MeAsp-Y-Adda-D-Glutamate-Mdha), where X and Y are variable L-65
amino acids, MeAsp and Mdha are Methylaspartic acid and Methyldehydroalanine, 66
respectively and Adda is (2S, 3S, 8S, 9S)-3-amino-9-methoxy-2,6,8-thrimethyl-10-67
phenyldeca-4(E),6(E)-dienoic acid [3].  There are over 90 variants of microcystins with 68
the most common being Microcystin-LR (MC-LR), which has Leucine at position 2 69
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and Arginine at position 4 [4, 3].  They are hepatotoxic, due to their uptake via the bile 70
acid transport system delivering them into hepatocytes, where they inhibit 71
Serine/Threonine Proteases via Adda, causing over phosphorylation of proteins.  Acute 72
toxicosis results in the disruption of the cytoskeleton, loss of cell structure and 73
adhesion, loss of tissue structure and the collapse of sinusoidal capillaries resulting in 74
hepatic haemorrhaging and ultimately death [5–8].  The deaths of 60 patients in a 75
dialysis unit in Brazil, in 1996, have been attributed to the use of contaminated water 76
during dialysis [9].  Lower levels of microcystins, although not acutely lethal, have 77
been shown to promote cancer (Group 2B carcinogen; possibly carcinogenic to 78
humans) and have immunotoxic and genotoxic effects [10–12].  The World Health 79
Organisation (WHO) have set the recommended limit at 1 µg l-1 for drinking water and 80
20 µg l-1 for recreational waters [13–15].  Microcystins are small (MC-LR being 995.2 81
Da) and stable compounds, withstanding harsh conditions, such as high temperatures 82
and extreme pH.  Removal is usually achieved by activated carbon filtration, ozonation 83
or chlorination; all being commonly utilised in water treatment [16–18].   84
85
The ability to detect microcystins is important and many tests exist.  The vast majority 86
are laboratory based, with immunoassays enabling high throughput screening for total 87
microcystin concentrations and analytical methods (such as HPLC, Mass 88
Spectrometry[19–21]), although slower, allowing the quantification and identification 89
of individual variants within a sample [22, 3].  Recent attention has turned towards the 90
on-site detection of microcystins.  Portable tests have long since focused on the lateral 91
flow format, a major drawback of which is that quantification usually relies on the 92
user’s determination.  However, the first lateral flow device (LFD) for microcystins, 93
devised by Kim et al (2003) [23], employed a custom made portable-laser fluorescence 94
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scanner, eliminating the subjective nature of results interpretation.  For this they used 95
Alexa Fluor 647®, a Cy5 labelled fluorescent probe, as the secondary, detection, 96
antibody, in a competitive assay, whereby a MC-LR conjugate was coated to the 97
surface and an anti-MC-LR monoclonal was used as the primary antibody.  This assay 98
format works well for most biosensors, including planar waveguide, a technology, that 99
has been around for decades.  Two portable assays, have been developed recently by 100
Long et al (2005) and Herranz et al (2012) [24, 25].  Both utilise modified versions of 101
the aforementioned assay format; Long et al use a Cy5 labelled monoclonal, and 102
Herranz coat the sensor surface with MC-LR as opposed to a MC-LR-conjugate.  The 103
biosensors used are the Trace Organic Pollutant Analyser (TOPA) and a 104
commercialised version of the US Naval Research Laboratory (NRL) Array Biosensor 105
prototype, by Long et al and Herranz et al respectively.  For the TOPA assay, one 106
analyte was measured at a time, with a cycle time of 20 min, 150 cycles per surface and 107
an LOD of 30 ng l-1.   The NRL Biosensor, can detect up to 6 analytes at a time, with 108
15 cycles per surface, a cycle time of 60 min and an LOD of 16 ng l-1.  The present 109
study utilises the next generation of evanescent wave/ planar waveguide detection. This 110
platform has all the advantages related to single use LFDs and portable biosensors yet 111
has the ability to perform the accurate quantification only associated with laboratory 112
based, methods. The unique MBio SnapEsi® LS sensor [26] employed in the present 113
study uses, a patented design, whereby the lens is integrated on a disposable cartridge; a 114
cartridge into which the sample and reagents are added and held.  The cartridges are 115
custom made, spotted with (in-house prepared) toxin-protein conjugates, chosen and 116
optimised for the sensitive and selective binding of anti-microcystin monoclonal 117
antibody (also produced in-house).  These cartridges eliminate the need for 118
cumbersome and expensive microfluidics often associated with advanced portable 119
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sensors, thus there is no need for pumps, valves, tubing or buffer/waste reservoirs.  In 120
the SnapEsi® LS assay there are no concerns about tubing becoming blocked; either by 121
lines drying out due to warm temperatures, air bubbles, or sample particulate blockages.  122
The cartridge can simply be used, read and disposed of.  Thus a simple to use, low cost 123
and accurate means of detecting microcystins will be presented. 124
125
Further to this, we present a highly novel sample preparation method for the portable 126
lysis of cyanobacterial, Microcystis aeruginosa, cells, for the quantification of intra-127
cellular microcystin levels. Microcystins are inherently endotoxins, therefore, the 128
measurement of freshwater only, fails to detect the majority of toxin present, as has 129
been highlighted by Codd et al (2005) [2] who state that guideline values “should 130
therefore apply to the sum of the intracellular and extracellular microcystin pools”; yet 131
the focus has remained on water testing only.  This may be in part due to the difficulties 132
encountered in dealing with cyanobacterial samples in current analytical methods. 133
Cheap, quick and portable lysis usually relies on chemical disruption of cells, using 134
harsh reagents which may interfere with downstream assays, causing matrix 135
interference and thus skewing results.  The best cellular disruption occurs via 136
mechanical lysis of the cells, such as that of glass bead beating, which has been 137
demonstrated to achieve full lysis of algal cells, in a quick time of only 10 min [27].  138
This laboratory based method required a paint shaker to mix the sample/glass bead 139
combination and a centrifuge to separate cells from freshwater samples.  To overcome 140
this, centrifugation steps were switched to filtration and the paint shaker was substituted 141
for a, low cost, hand-held, battery operated frother.  Other non mechanical methods 142
require filtration of the sample (glass fibre filters, GF/C) followed by slow toxin 143
extraction using solvents which are not compatible with immunoassays.144
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145
Presented here is an assay, proven to be capable of detecting microcystins in both free 146
and intracellular states, to a level of 1 ng ml-1 for free and 0.1 ng ml-1 for intracellular 147
microcystins.  This rapid, semi-quantitative test, has an assay time of only 15 min for 148
free microcystins, and under 30 min for intracellular microcystins, inclusive of sample 149
preparation. 150
151
152
153
154
2. Materials and Methods155
156
2.1. Reagents and Chemicals 157
Microcystin-LR was purchased from Enzo Life Sciences, through Alpha Technologies 158
Ltd, Larne Northern Ireland.  Bovine Serum Albumin (BSA), Phosphate buffered saline 159
(PBS) tablets, Tween-20 and apo-Transferrin (bovine) were purchased from Sigma-160
Aldrich, Gillingham, UK.  Cyanobacterial cultures were obtained from the Culture 161
Collection of Algae and Protozoa (CCAP), Oban, Scotland and the Laboratory of 162
Ecotoxicology, Genomics and Evolution (LEGE) at the Centre of Marine and 163
Environmental Research (CIIMAR), Porto, Portugal.  From CCAP M. aeruginosa strains 164
1450/3 (non-toxic) and 1450/6 (toxic) were purchased and from CIIMAR, strains 165
LEGE 91093, LEGE 91094, LEGE 91095 and LEGE 91096 were received.  Jaworski's 166
and BG11 media were purchased from CCAP, Oban, Scotland.  Alexa Fluor 647 goat 167
anti—rabbit IgG and Alexa Fluor 647 goat anti—mouse IgG antibodies were purchased 168
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from Invitrogen Ltd, Paisley, Scotland.  The anti-microcystin, 5C4, monoclonal was 169
prepared in-house and details will be published elsewhere. 170
171
2.2. Apparatus172
For cell lysis a hand held frother was purchased from Argos Direct, Stafford, UK, while 173
the paint shaker, a Minimix standard shaker, was purchased from Merris Engineering, 174
Berkshire, UK.  Swinnex, 25 mm filter holders, 25mm gaskets and 25 mm MF-175
Millipore (mixed cellulose esters, hydrophilic, 0.45 µm and black gridded) membranes, 176
together with Millex-HA (0.45 µm, mixed cellulose) filters were purchased through 177
Premier Scientific Ltd, Belfast, Northern Ireland.  The SnapEsi® LS System [28] was 178
supplied by MBio Diagnostics Inc, Boulder, Colorado, USA, as were the microarray 179
cartridges.  180
181
2.3. Preparation of Toxin Protein Conjugate (TPC); 182
MC-LR-Transferrin   183
MC-LR, 0.25 mg, was reconstituted in 50 µl Dimethyl sulfoxide (DMSO).  To this was 184
added 50 µl N-Hydroxysuccinimide (NHS) (130 mM) and 100 µl N-(3-185
Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) (39 mM), both 186
dissolved in 50 mM 2-(N-Morpholino) ethanesulfonic acid (MES), pH 4.7.  This was 187
stirred for 30 min, protected from light, at room temperature.  The active ester solution 188
was then added, dropwise to a vial containing 1 mg of Transferrin dissolved in 1 ml 189
PBS pH 7.4.  This was stirred at room temperature, for 2 hours, again protected from 190
light.  The TPC was dialysed against PBS pH 7.4 and tested by ELISA.  The TPC was191
sent to mBio Diagnostics for microarray printing, at 100 µg ml-1.  192
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193
2.4. Microarray Printing194
 Microarrays were printed using a Bio-Dot AD3200 robotic arrayer.  Briefly, spots were 195
produced, with a diameter of 0.5 mm, using a Bio-Jet print head that dispensed 20 nl.  196
Four replicates of the TPC were printed onto a grid with 1 mm centres.  Microarrays 197
were then blocked with a protein-based blocking agent (0.5% casein in PBS with 198
Proclin300 antimicrobial) prior to spin-drying.  Microarrays were then assembled into 199
an injection moulded cartridge, which contained a 5 mm wide fluidic channel (max 200
volume 30 µl) with a single inlet port for the addition of sample and reagents.  Assays 201
were carried out on a rack, angled for optimum flow rate, enhancing passive fluid flow, 202
which is aided by capillarity due to the narrow fluidic channel.  203
204
2.5.Culturing 205
CCAP cultures were maintained in Jaworski's Medium, while CIIMAR LEGE cultures 206
were maintained in BG11 Medium.  Culturing was done in glass Erlenmeyer flasks 207
(wide necked) with cotton wool plugs and foil lids and incubated at 20 °C with a light 208
intensity of 116 µmol m-2 s-1.  All consumables were sterilised by autoclaving at 121 °C 209
for 15 min.  Culturing work was carried out in a pre-sterilised (via 30 min UV 210
exposure) UV3 HEPA PCR cabinet.  Cultures were maintained in log phase, with fresh 211
cultures being seeded from denser cultures (nearing stationary phase); 40 ml dense 212
culture added to 160 ml fresh media.  Culture growth was monitored by cell counting 213
using Lugol’s stain and a haemocytometer under x200 magnification.  214
215
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2.6. Sample Lysis216
A 25 mm swinnex filter (in a 25 mm Swinnex Filter Holder) was used to filter 50 ml of 217
sample/culture.  The filter membrane was then transferred to a 7 ml bijou and the 218
captured cells resuspended with 5 ml PBS pH 7.4.  To 5 ml of sample/culture, 1 g of 219
0.1 mm glass beads was added to a small glass beaker (15 ml), whose diameter was just 220
large enough to accommodate the frother whisk, whilst limiting the space for 221
beads/cells to accumulate in.  The frother was then switched on and allowed to ‘whisk’ 222
the sample/bead mixture for 10 min.  Once finished the sample was twice filtered (0.45 223
µm Millipore), to ensure complete removal of glass beads/fragments; once should be 224
enough, but a second filtration was included in case the first filter was perforated.  A 225
negative toxin producer (CCAP 1450/3) was treated in the same way to produce the 226
matrix in which calibrants are prepared.  227
228
2.7. Assay229
Reagent/Sample Preparation230
Assay Buffer231
The buffer was PBS pH 7.4 containing 0.05% Tween-20, 0.45 µm filtered. 232
233
Antibody Solutions234
The monoclonal antibody, 5C4 was diluted (v/v), 1 in 100, from the stock solution of 235
approximately 0.88 mg ml-1.  The diluent was Assay Buffer containing 1% BSA, the 236
BSA acting as a stabiliser.  The working stock was maintained at 4 °C and diluted 237
again, with Assay Buffer (without the added BSA) to a final concentration of 1 in 238
10000, for use in the assay.  The 5C4 monoclonal antibody was shown to have cross-239
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reactivity for the most common microcystin variants, as follows: MC-RR, 108%; MC-240
YR, 68%; MC-LA, 69%; MC-LW, 71%; MC-LF, 68%; and Nodularin, 94%. 241
242
The detection antibody, Alexa Fluor 647 goat anti-mouse IgG, was used to prepare a 243
detection antibody working stock solution, also stored at 4 °C (without added BSA), 244
protected from light.  The stock solution was prepared by adding 100 µl of each 245
antibody to 2 ml of Assay Buffer.  For use in assay conditions, a further 1 in 10 dilution 246
(with Assay Buffer) was required to get to the final 10 µg ml-1 working solution.  247
248
Calibrants249
Calibrants were prepared from a 1 µg ml-1 solution of MC-LR, to yield concentrations 250
of 200, 50, 20 and 0 ng ml-1, with dilutions made using Assay Buffer.  These were then 251
used to spike 950 µl of matrix, using 50 µl per spike, to get final solutions with the 252
following concentrations:  10, 2.5, 1 and 0 ng ml-1.  253
254
Assay Conditions255
Equal volumes of 5C4 antibody and sample/calibrant were mixed and 150 µl 256
immediately applied to the cartridge.  After 7 ½ min, 150 µl of detection antibody was 257
added.  After 7 ½ min (15 min total time) the cartridge was read using the SnapEsi 258
reader.  259
260
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2.8.Liquid Chromatography Tandem- Mass Spectrometry 261
(LC-MS/MS) Validation 262
Freeze-drying and solid phase extraction (SPE) were used to prepare and extract263
microcystins from Microcystis aeruginosa samples for LC-MS/MS detection, as 264
reported elsewhere; using modified methods from Kim et al. (2009), Lawton et al. 265
(1994), Msagati et al. (2006) and Mooney et al. (2011) [29–31, 20].  Briefly, 50 ml 266
samples were freeze-dried and resuspended in, 5 ml, 75% methanol before enrichment 267
and purification with OASIS HLB cartridges, after the methanol content was diluted to 268
15%.  Microcystins were eluted with 6 ml methanol, containing 0.1% Trifluoroacetic 269
acid, dried under nitrogen, resuspended in 80% methanol and analysed by LC-MS/MS; 270
using a Waters Acquity UPLC and a Quattro Premier XE Mass Spectrometer, run in 271
electrospray positive mode (ESI).272
273
2.9. Surface Plasmon Resonance (SPR) Assay274
275
CM5 research grade chips were used on a Biacore Q instrument.  CM5 chips were 276
coated with MC-LR using the method devised by Vinogradova et al [32].  The flow rate 277
was 20 µl min-1 for 4 min per cycle, with the 5C4 monoclonal antibody used at a 1 in 278
1000 dilution (v/v) using the 0.88 mg ml-1 stock solution.  5C4 was mixed with sample 279
prior to injections using a blend of 30% antibody and 70% sample.  The calibration 280
curve consisted of six points; 10, 5, 2.5, 1, 0.5 and 0 ng ml-1 MC-LR.  Calibrants were 281
prepared in matrix (M. aeruginosa CCAP 1450/3 lysate) to normalise for matrix 282
effects.  Regeneration of the chip surface was achieved by injecting 75 mM Sodium 283
hydroxide and 10% Acetonitrile (in deionised water) for 1 min at 20 µl min-1.284
   285
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3. Results and Discussion286
3.1.Milk Frother Validation287
Validation of the frother required testing samples lysed by both the laboratory based 288
paint shaker [27] and portable frother by SPR.  This was due to the observation that 289
disintegration of the glass beads occurred upon mixing, which resulted in the 290
appearance of small fragments, which could be mistaken for M. aer cells when viewed 291
microscopically, See Fig 1 for images.  To overcome this, identical samples were tested 292
by SPR.  For one sample, the paint shaker and 0.5 mm beads were employed and for 293
the other the frother and 0.1 mm beads were used.  The ratio of 1 g per 2 ml of sample 294
was maintained, thus 2.5 g of 0.1 mm glass beads were added to the 5 ml sample.  The 295
same mixing time was used for both, 10 min.  The final samples were then tested by 296
SPR to determine the toxin concentrations present.  The concentration as determined by 297
the paint shaker method was 9.0 ng ml-1, while that of the frother method was 9.25 ng 298
ml-1, resulting in a 103 % recovery of microcystin..  This confirmed that the lysis 299
procedure was as effective as that of the paint shaker.  300
301
3.2.Assay Format302
The format of the assay was competitive inhibition, whereby the more microcystins that 303
were present in a sample/calibrant, the less anti-microcystin, 5C4, monoclonal there 304
was available to bind to the surface bound TPC.  Thus the more microcystins present in 305
a given sample, the lower the signal would be.  This is shown in Fig 2, showing the 306
fluorescence recorded for the four identical microcystin spots, on cartridges with 307
calibrants added.  308
309
310
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3.3.Assay Validation311
The limit of detection (LOD) was determined by taking the mean response for 20 312
negative (toxin free) samples and subtracting 3x standard deviations (S.D.) as is 313
standard for inhibition assays [33].  The response was then converted to concentration 314
via the calibration curve and derived as 0.78 ng ml-1 (see Table 1).  This level was used 315
as a guide to estimate the detection capability (CCβ), which was 1 ng ml-1, equivalent 316
of the 1 µg l-1 WHO recommended level.  Taking into consideration the 10-fold 317
concentration step in the sample preparation method for intra-cellular measurement, 318
this brings samples containing 0.1 ng ml-1 into the measureable range of the calibration 319
curve.  No sample preparation method, other than filtration (0.45 µm) was included for 320
free microcystin measurement, as this would only serve to reduce the speed of analysis.  321
As can be seen from Fig 3, there was no overlap between the 20 x 1 ng ml-1 spiked 322
samples and the 20 negative samples from the LOD calculation (to 1x S.D.).  323
Populations were also shown to be significantly different with a p value < 0.0001; 2-324
tailed, unpaired t-test.  The assay had a dynamic range (IC10 to IC90) of 0.22 to 5.12 ng 325
ml-1.  326
327
Repeatability and reproducibility (intra- and inter-run robustness) were demonstrated 328
by spiking at 3 different toxin  levels, with 4 replicates per spiking level, across 2 329
batches of cartridges and repeating this over 3 days.  The data was then analysed per 330
day to determine repeatability of the assay and then across the 3 days to determine the 331
reproducibility of the assay.  The 3 spiking levels chosen were CCβ, the midpoint (IC50) 332
and the level at which 75% inhibition of signal was achieved (IC75), which were 1, 1.27 333
and 2.78 ng ml-1 respectively.  Inter-run analysis showed that spiking level recoveries 334
all lay between 78 and 91% with % C.V.s lower than 15% (see Table 2).  For intra-run 335
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analysis, recoveries were between 73 and 96 % with % C.V.s below 22% (see Table 2).  336
This demonstrated a high degree of repeatability for what is a semi-quantitative assay, 337
and providing  values that could be expected with a fully quantitative, laboratory based 338
assay, 339
340
Final validation of the assay was performed by testing samples by the SnapEsi method 341
and comparing them to values determined by LC-MS/MS analysis.  Table 3 shows the 342
calculated concentrations of the 5 M aeruginosa strains tested.  The two microcystin 343
pools were combined to give a total microcystin content of each sample.  These were 344
then compared to the concentrations derived by LC-MS/MS analysis and as can be seen 345
from the data in Table 4 the difference between the calculated concentrations is 346
between 0.8 to 1.3-fold, with an average of a 1.04-fold difference.  Differing sample 347
preparation methods in addition to the differing detection methods generally result in 348
much greater variation in data generated.  The R2 value, when the calculated 349
concentrations were plotted against each other, Fig 4, was 0.9954, demonstrating the 350
reliability and accuracy of the method.  351
352
4. Conclusions353
Due to the true and accurate level of microcystins in a water sample only being 354
ascertained if both free and cell-bound levels are quantified, a method has been 355
developed, and fully validated, to allow the calculation of the total microcystin content 356
of a sample.  To allow for the development of a rapid and portable assay, a novel 357
method of cell lysis was also developed and validated, whereby a frother was used to 358
vigorously agitate a sample containing, 0.1 mm glass beads, mechanically lysing the 359
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cyanobacterial cells, without the need for harsh chemicals, in just 10 min.  The planar 360
waveguide assay, using a SnapEsi® LS sensor, is rapid, taking only 15 min and using 361
an anti-microcystin monoclonal antibody (5C4), that detects the more common, and 362
toxic, variants of microcystin; MC-LR, MC-RR, MC-YR, MC-LA, MC-LW and MC-363
LF.  The assay can detect free microcystins to 1 ng ml-1 and intracellular microcystins 364
to 0.1 ng ml-1.  The difference being due to a 10x concentration step that was included 365
in the intracellular sample preparation method; no sample preparation method was 366
required in the measurement of the free microcystin fraction. In addition to this, a 367
single, cheap, cartridge is used per sample that is simply discarded after reading, to give 368
an assay that is not only rapid and portable, but has quantitative capabilities that many 369
semi-quantitative laboratory based methods fail to reach. 370
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List of Figures:443
Fig 1.  Image a (x 200 magnification) shows 0.1 mm glass beads after 10 min mixing 444
with the milk frother.  The majority of beads disintegrate forming small fragments that 445
may be mistaken for cyanobacterial cells.  Image b (x 200 magnification) shows CCAP 446
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1450/6 M. aeruginosa cells; which would be difficult to distinguish amongst the bead 447
fragments in image a.  448
Fig 2.  Images of microcystin spots as treated with calibrants: a, 10 ng ml-1; b, 449
2.5 ng ml-1; c, 1 ng ml-1; and d, 0 ng ml-1. 450
Fig 3. Determination of CCβ as 1 ng ml-1, as shown by the 0 ng ml-1 and 1 ng ml-1451
populations not overlapping (to 1 S.D.)452
Fig 4. Comparison of mBio and LC-MS/MS results, showing a good correlation, 453
whereby R2 = 0.9954.  454
455
List of Tables:456
Table 1. Determination of LOD as 0.78 ng ml-1457
Table 2.  Measured concentrations of spiked samples, along with S.D., % C.V.s and 458
mean recoveries, for repeatability and reproducibility analysis of assay.459
Table 3.  Microcystin content of M. aeruginosa cultures as calculated by mBio 460
SnapEsi. 461
Table 4.  Comparison of mBio and mass spec concentrations for toxin producing M. 462
aeruginosa samples.  463
464
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464
Response (Normalised Signal)
Mean S.D. %C.V. 3x[S.D.] LOD
Calc Conc 
(ng ml-1)
1060.9 133.8 12.6 401.4 659.5 0.78
465
466
467
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467
Spiking Level
(ng ml-1)
Measured 
Concentration 
(ng ml-1) ± S.D.
C.V. (%)
Mean 
Recovery (%)
1 0.95 ± 0.13 14.0 95.1
1.27 0.99 ± 0.28 21.9 78.2Day 1
2.78 2.03 ± 0.39 19.3 73.1
1 0.86 ± 0.13 15.5 85.9
1.27 1.06 ± 0.28 26.3 83.3Day 2
2.78 2.02 ± 0.36 17.6 72.6
1 0.91 ± 0.10 10.5 90.9
1.27 1.29 ± 0.11 8.4 101.3Day 3
2.78 2.49 ± 0.44 17.8 89.4
1 0.91 ± 0.05 5.0 90.6
1.27 1.11 ± 0.15 13.9 87.6
Overall 
(Days 1 to 3)
2.78 2.18 ± 0.27 12.2 78.4
468
469
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469
Culture
Cell bound 
Concentration 
(ng ml-1)
Free Concentration 
(ng ml-1)
Total Concentration 
(ng ml-1)
1450/06 7.9 21.2 29.2
91093 63.6 16.5 80.1
91094 38.7 21.6 60.3
91095 128.2 461.5 589.7
91096 72.5 18.2 90.7
470
471
472
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472
Calculated Concentration (ng/ml)
Culture
mBio Mass Spec
Difference 
(x-fold)
1450/06 29.2 23.7 0.8
91093 80.1 108.1 1.3
91094 60.3 64.5 1.1
91095 589.7 536.2 0.9
91096 90.7 98.9 1.1
473
474
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1. Sample Filtration 2. Resuspension of cells 3. Sample Lysis 
4. Sample filtration 5. Application of sample 6. Read Signal 
*Graphical Abstract (for review)
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Figure 3 - Revised
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Figure 4
